A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the ...
Tech Xplore on MSN
Engineers tackle pre-ignition challenges in hydrogen-fueled engines
Engineers at Southwest Research Institute (SwRI) have developed a reliable testing methodology to study stochastic pre-ignition (SPI) in hydrogen-fueled internal combustion engines (H2-ICEs), offering ...
MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory filing ...
China's domestically produced 300-megawatt F-class heavy-duty gas turbine completed its first ignition in Shanghai on Monday, marking a significant advancement in the country's gas turbine technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback